SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(van Vollenhoven R.)
 

Sökning: WFRF:(van Vollenhoven R.) > A framework for rem...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004936naa a2200949 4500
001oai:prod.swepub.kib.ki.se:135295823
003SwePub
008240825s2017 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1352958232 URI
024a https://doi.org/10.1136/annrheumdis-2016-2095192 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a van Vollenhoven, Ru Karolinska Institutet4 aut
2451 0a A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
264 c 2016-11-24
264 1b BMJ,c 2017
520 a Treat-to-target recommendations have identified ‘remission’ as a target in systemic lupus erythematosus (SLE), but recognise that there is no universally accepted definition for this. Therefore, we initiated a process to achieve consensus on potential definitions for remission in SLE.MethodsAn international task force of 60 specialists and patient representatives participated in preparatory exercises, a face-to-face meeting and follow-up electronic voting. The level for agreement was set at 90%.ResultsThe task force agreed on eight key statements regarding remission in SLE and three principles to guide the further development of remission definitions:1. Definitions of remission will be worded as follows: remission in SLE is a durable state characterised by …………………. (reference to symptoms, signs, routine labs).2. For defining remission, a validated index must be used, for example, clinical systemic lupus erythematosus disease activity index (SLEDAI)=0, British Isles lupus assessment group (BILAG) 2004 D/E only, clinical European consensus lupus outcome measure (ECLAM)=0; with routine laboratory assessments included, and supplemented with physician's global assessment.3. Distinction is made between remission off and on therapy: remission off therapy requires the patient to be on no other treatment for SLE than maintenance antimalarials; and remission on therapy allows patients to be on stable maintenance antimalarials, low-dose corticosteroids (prednisone ≤5 mg/day), maintenance immunosuppressives and/or maintenance biologics.The task force also agreed that the most appropriate outcomes (dependent variables) for testing the prognostic value (construct validity) of potential remission definitions are: death, damage, flares and measures of health-related quality of life.ConclusionsThe work of this international task force provides a framework for testing different definitions of remission against long-term outcomes.
700a Voskuyl, A4 aut
700a Bertsias, G4 aut
700a Aranow, C4 aut
700a Aringer, M4 aut
700a Arnaud, L4 aut
700a Askanase, A4 aut
700a Balazova, P4 aut
700a Bonfa, E4 aut
700a Bootsma, H4 aut
700a Boumpas, D4 aut
700a Bruce, I4 aut
700a Cervera, R4 aut
700a Clarke, A4 aut
700a Coney, C4 aut
700a Costedoat-Chalumeau, N4 aut
700a Czirjak, L4 aut
700a Derksen, R4 aut
700a Doria, A4 aut
700a Dorner, T4 aut
700a Fischer-Betz, R4 aut
700a Fritsch-Stork, R4 aut
700a Gordon, C4 aut
700a Graninger, W4 aut
700a Gyori, N4 aut
700a Houssiau, F4 aut
700a Isenberg, D4 aut
700a Jacobsen, S4 aut
700a Jayne, D4 aut
700a Kuhn, A4 aut
700a Le Guern, V4 aut
700a Lerstrom, K4 aut
700a Levy, R4 aut
700a Machado-Ribeiro, F4 aut
700a Mariette, X4 aut
700a Missaykeh, J4 aut
700a Morand, E4 aut
700a Mosca, M4 aut
700a Inanc, M4 aut
700a Navarra, S4 aut
700a Neumann, I4 aut
700a Olesinska, M4 aut
700a Petri, M4 aut
700a Rahman, A4 aut
700a Rekvig, OP4 aut
700a Rovensky, J4 aut
700a Shoenfeld, Y4 aut
700a Smolen, J4 aut
700a Tincani, A4 aut
700a Urowitz, M4 aut
700a van Leeuw, B4 aut
700a Vasconcelos, C4 aut
700a Voss, A4 aut
700a Werth, VP4 aut
700a Zakharova, H4 aut
700a Zoma, A4 aut
700a Schneider, M4 aut
700a Ward, M4 aut
710a Karolinska Institutet4 org
773t Annals of the rheumatic diseasesd : BMJg 76:3, s. 554-561q 76:3<554-561x 1468-2060x 0003-4967
856u http://diposit.ub.edu/dspace/bitstream/2445/123199/1/678610.pdf
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:135295823
8564 8u https://doi.org/10.1136/annrheumdis-2016-209519

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy